Pharmaceutical Business review

KineMatik names new president and CEO

Before joining KineMatik, Mr Jarjour was vice president of global marketing at Organon. Previously, Mr Jarjour held key positions at top tier pharmaceutical organizations including Bristol-Myers Squibb, Pharmacia, Warner Lambert and Wyeth.

Mr Jarjour holds a BS in finance from Florida International University and an MBA from the Rutgers University.

Harry Lorton, chairman of the board of directors at KineMatik, said: “We are delighted to welcome Michael to the KineMatik team. His extensive experience in sales, marketing, operations and strategic planning, combined with his background and entrepreneurial skills in the life sciences and technology industries, will help us consolidate our position as leaders in the scientific enterprise content of management space.”